What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos

1

Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers

2

Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge

3

Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more
Close
With rendition switcher

Transcript

Question: Why aren't our methods of developing drugs more advanced?

Jay Parkinson:  The methods of developing drugs are sort of set up so that you try to control for a similar group of people and you give them a similar pill.  But the deal is, we don't know anything about their genetics.  So, maybe they have these certain enzymes in their body that like really turn this drug over and turn it into the active metabolite for example that helps you, or maybe you're a bad metabolizer and it builds up in your liver and causes problems. 

The deal is, the pharmaceutical companies would rather have their market not limited by 66 percent, they would just like to sort of create a drug for everybody, throw it out to the masses, and if it improves symptoms by 5 percent, well it's a drug, and it's done it's job.  But in actuality, whenever you look at it across the population, there's a significant amount of people that are harmed by that drug.  The FDA tries to eliminate that as much as possible, but it doesn't always work. 

Question: Should we still be taking drugs?

Jay Parkinson: I think that there are certain drugs that we should not be taking, absolutely.  In 2009, the FDA approved only 26 drugs.  Seventy percent of those were the Me2 drugs, drugs that were going off patent, and needed to be remarketed as the next "Purple Pill" for example.  In order to create a $400 a month blockbuster drug in exchange for a $4.00 a month generic.  I think that is a very, very, very shady practice and it's harming our health in exchange for creating a whole industry of profitability of selling snake oil and marketing gimmicks.

Recorded on March 9, 2010

 

Should We Stop Taking Drugs?

Newsletter: Share: